Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance
10.21037/tlcr-22-661
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
AME PUBLISHING COMPANY
2024
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/248897 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| Language: | English |
| id |
sg-nus-scholar.10635-248897 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2488972024-11-15T08:45:48Z Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance Ma, Jun Tan, Sze Huey Yin, Daniel Xing Cheng Tran, Nguyen Tuan Anh San Tan, Gek Lai, Gillianne Geet Yi Ang, Mei-Kim Kanesvaran, Ravindran Jain, Amit Rajasekaran, Tanujaa Tan, Eng-Huat Lim, Tony Kiat Hon Tan, Daniel Shao-Weng Lim, Darren Wan-Teck Ng, Quan Sing Tan, Wan Ling DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) DUKE-NUS MEDICAL SCHOOL BIOCHEMISTRY Assoc Prof Wan-Teck Darren Lim Science & Technology Life Sciences & Biomedicine Oncology Respiratory System MUTATIONS AFATINIB NSCLC TKI TECHNOLOGIES AZD9291 10.21037/tlcr-22-661 TRANSLATIONAL LUNG CANCER RESEARCH 12 4 742-753 2024-06-14T05:44:16Z 2024-06-14T05:44:16Z 2023-04 2024-06-12T13:47:50Z Article Ma, Jun, Tan, Sze Huey, Yin, Daniel Xing Cheng, Tran, Nguyen Tuan Anh, San Tan, Gek, Lai, Gillianne Geet Yi, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Rajasekaran, Tanujaa, Tan, Eng-Huat, Lim, Tony Kiat Hon, Tan, Daniel Shao-Weng, Lim, Darren Wan-Teck, Ng, Quan Sing, Tan, Wan Ling (2023-04). Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance. TRANSLATIONAL LUNG CANCER RESEARCH 12 (4) : 742-753. ScholarBank@NUS Repository. https://doi.org/10.21037/tlcr-22-661 2218-6751 2226-4477 https://scholarbank.nus.edu.sg/handle/10635/248897 en AME PUBLISHING COMPANY Elements |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| language |
English |
| topic |
Science & Technology Life Sciences & Biomedicine Oncology Respiratory System MUTATIONS AFATINIB NSCLC TKI TECHNOLOGIES AZD9291 |
| spellingShingle |
Science & Technology Life Sciences & Biomedicine Oncology Respiratory System MUTATIONS AFATINIB NSCLC TKI TECHNOLOGIES AZD9291 Ma, Jun Tan, Sze Huey Yin, Daniel Xing Cheng Tran, Nguyen Tuan Anh San Tan, Gek Lai, Gillianne Geet Yi Ang, Mei-Kim Kanesvaran, Ravindran Jain, Amit Rajasekaran, Tanujaa Tan, Eng-Huat Lim, Tony Kiat Hon Tan, Daniel Shao-Weng Lim, Darren Wan-Teck Ng, Quan Sing Tan, Wan Ling Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance |
| description |
10.21037/tlcr-22-661 |
| author2 |
DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) |
| author_facet |
DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) Ma, Jun Tan, Sze Huey Yin, Daniel Xing Cheng Tran, Nguyen Tuan Anh San Tan, Gek Lai, Gillianne Geet Yi Ang, Mei-Kim Kanesvaran, Ravindran Jain, Amit Rajasekaran, Tanujaa Tan, Eng-Huat Lim, Tony Kiat Hon Tan, Daniel Shao-Weng Lim, Darren Wan-Teck Ng, Quan Sing Tan, Wan Ling |
| format |
Article |
| author |
Ma, Jun Tan, Sze Huey Yin, Daniel Xing Cheng Tran, Nguyen Tuan Anh San Tan, Gek Lai, Gillianne Geet Yi Ang, Mei-Kim Kanesvaran, Ravindran Jain, Amit Rajasekaran, Tanujaa Tan, Eng-Huat Lim, Tony Kiat Hon Tan, Daniel Shao-Weng Lim, Darren Wan-Teck Ng, Quan Sing Tan, Wan Ling |
| author_sort |
Ma, Jun |
| title |
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance |
| title_short |
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance |
| title_full |
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance |
| title_fullStr |
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance |
| title_full_unstemmed |
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance |
| title_sort |
real world efficacy of osimertinib in second line/beyond in patients with metastatic egfr plus non-small cell lung cancer and role of paired tumour-plasma t790m testing at tyrosine kinase inhibitor resistance |
| publisher |
AME PUBLISHING COMPANY |
| publishDate |
2024 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/248897 |
| _version_ |
1821192656188866560 |